Management of PAH associated with systemic lupus erythematosus (SLE) or mixed connective tissue disease (MCTD): immunosuppressive therapy (IT) alone or combined with PAH specific therapies?

X. Jais, D. Launay, A. Yaici, O. Sitbon, J. Le Pavec, B. Sztrymf, C. Tcherakian, A. M. Hamid, L. Achouh, F. Parent, G. Simonneau, M. Humbert (Clamart, Lille, France)

Source: Annual Congress 2007 - Pulmonary hypertension
Session: Pulmonary hypertension
Session type: Thematic Poster Session
Number: 2086
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
X. Jais, D. Launay, A. Yaici, O. Sitbon, J. Le Pavec, B. Sztrymf, C. Tcherakian, A. M. Hamid, L. Achouh, F. Parent, G. Simonneau, M. Humbert (Clamart, Lille, France). Management of PAH associated with systemic lupus erythematosus (SLE) or mixed connective tissue disease (MCTD): immunosuppressive therapy (IT) alone or combined with PAH specific therapies?. Eur Respir J 2007; 30: Suppl. 51, 2086

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Examining pulmonary function measures in patients with systemic lupus erythematosus (SLE)
Source: Virtual Congress 2020 – Rare lung diseases and lung manifestations of extrapulmonary diseases
Year: 2020

Pulmonary involvement in systemic lupus erythematosus, Sjögren syndrome and mixed connective tissue disease
Source: Eur Respir Monogr 2019; 86: 106-123
Year: 2019


Lung involvement in systemic lupus erythematosus (SLE) - our own experience
Source: Eur Respir J 2002; 20: Suppl. 38, 60s
Year: 2002

Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus
Source: Eur Respir Rev 2011; 20: 277-286
Year: 2011



Systemic lupus erythematosus-associated PAH: is targeting inflammation the key to success?
Source: Eur Respir Rev 2011; 20: 218-219
Year: 2011


Systemic lupus erythematosus (SLE): Cyto- and chemokines as possible serum markers for pulmonary involvement?
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012

Interstitial lung disease associated with systemic lupus erythematosus : a monocentric study of 23 cases.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021


On diagnostics of pneumonitis in patients with lupus erythematosus (LE)
Source: Eur Respir J 2005; 26: Suppl. 49, 31s
Year: 2005

Shrinking lung syndrome (SLS) associated with systemic lupus erythematosus (SLE): A series of cases in a university hospital.
Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives
Year: 2019



Effectiveness of ²Korargin² in the therapy of pulmonary arterial hypertension in patients with systemic lupus erythematosus
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011

Lung abnormalities in patients with systemic lupus erythematosus
Source: Eur Respir J 2001; 18: Suppl. 33, 225s
Year: 2001

Immunosuppression in systemic lupus erythematosus associated pulmonary arterial hypertension (SLE-APAH): Improvement in exercise and functional capacity
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011


Management and prognosis of respiratory manifestations revealing systemic lupus erythematosus
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007


Endothelium dysfunction in systemic lupus erythematosus patients with pulmonary hypertension
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011


A functionally improved case of obstructive impairment caused by systemic lupus erythematosus
Source: Breathe, 17 (2) OE01; 10.1183/20734735.0288-2020
Year: 2021



The profile of lung scintigraphy in systemic lupus erythematosus with chronic pulmonary embolism:a cross-section
Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Year: 2020


Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study
Source: ERJ Open Res, 4 (1) 00135-2017; 10.1183/23120541.00135-2017
Year: 2018



The prevalence of respiratory disease in a cohort of patients with systemic lupus erythematosus (SLE) in a large Irish teaching hospital
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007


Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016


Pulmonary manifestations in systemic lupus erythematosus (SLE) and changes in peripheral blood CD4+ lymphocyte subsets
Source: Annual Congress 2010 - Clinical aspects of asthma and allergic respiratory diseases
Year: 2010